common.study.topics.clinical

Ivabradine for Rate Control in Permanent Atrial Fibrillation

common.study.values.description

Ivabradine for Rate Control in Permanent Atrial Fibrillation

Ivabradine may be useful as a rate controlling agent in atrial fibrillation without negative effects on hemodynamics and inotropy. The objective in this proof of concept study is to investigate the hypothesis that ivabradine will slow the ventricular response in patients with permanent atrial fibrillation and previously-implanted pacemakers.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Ivabradine

Ivabradine will be started and titrated to heart rate slowing of 20 bpm or greater, or an increase in pacing.

participant.views.study.view.additional

participant.views.study.view.scientific-title

Ivabradine for Rate Control in Permanent Atrial Fibrillation

common.study.values.clinical-trial-id

NCT03987204

participant.views.study.view.id

eXD9ge